Prostate cancer accounts for around one fifth of all male cancers, and most men with prostate cancer receive hormone therapy. This is often effective, however, in most cases progression occurs over time. This training course explores the latest clinical trials investigating new treatment options for patients with newly diagnosed mHSPC, including discussion of the ramifications of their findings for treatment in both the USA and Europe.